| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:SDZ-NVI-085;SDZNVI085
CAS:104195-17-7
Purity:98% Package:5 mg
|
| Company Name: |
CHEMICAL LAND21
|
| Tel: |
82- 2 -783 - 8063 |
| Email: |
sales21@chemicalland21.com |
| Products Intro: |
|
|
| | SDZ NVI-085 Basic information |
| Product Name: | SDZ NVI-085 | | Synonyms: | SDZ NVI-085;[4aR,(-)]-3,4,4aβ,5,10,10aα-Hexahydro-6-methoxy-4-methyl-9-methylthio-2H-naphth[2,3-b]-1,4-oxazine;naphtoxazine;2H-Naphth[2,3-b]-1,4-oxazine, 3,4,4a,5,10,10a-hexahydro-6-methoxy-4-methyl-9-(methylthio)-, (4aR,10aR)- | | CAS: | 104195-17-7 | | MF: | C15H21NO2S | | MW: | 279.4 | | EINECS: | | | Product Categories: | | | Mol File: | 104195-17-7.mol |  |
| | SDZ NVI-085 Chemical Properties |
| Boiling point | 417.6±45.0 °C(Predicted) | | density | 1.19±0.1 g/cm3(Predicted) | | pka | 7.45±0.20(Predicted) |
| | SDZ NVI-085 Usage And Synthesis |
| Description | SDZ-NVI-085, also known as Naphtoxazine, is an α1 adrenergic receptor agonist potentially for the treatment of cognitive disorders and major depressive disorder. SDZ-NVI-085 behaves as a competitive antagonist of 5-hydroxytryptamine. SDZ-NVI-085 shifted 5-HT concentration-effect curves to the right, in a concentration-dependent manner, and Schild regression gave a pA2 estimate of 8.0. |
| | SDZ NVI-085 Preparation Products And Raw materials |
|